BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24377835)

  • 1. The Medicare Part D coverage gap: implications for non-dually eligible older adults with a mental illness.
    Bakk L; Woodward AT; Dunkle RE
    J Gerontol Soc Work; 2014; 57(1):37-51. PubMed ID: 24377835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Medicare modernization act on dually eligible persons with psychiatric diagnoses: a New York State case study.
    Jones K; Siegel C; Bertollo DN; Samuels J
    Psychiatr Serv; 2009 Apr; 60(4):512-9. PubMed ID: 19339327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
    West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
    J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
    Donohue JM; Frank RG
    Psychiatr Serv; 2007 Oct; 58(10):1285-91. PubMed ID: 17914004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifting Medicaid barriers. States work to upgrade IT to meet 2014 deadline.
    Daly R
    Mod Healthc; 2012 Jan; 42(4):8-9. PubMed ID: 22359761
    [No Abstract]   [Full Text] [Related]  

  • 6. Case managers and the use of Medicare, Part D.
    Hensley MA
    Prof Case Manag; 2011; 16(6):301-8. PubMed ID: 21986973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicaid eligibility. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-14. PubMed ID: 21370533
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.
    Madden JM; Adams AS; LeCates RF; Ross-Degnan D; Zhang F; Huskamp HA; Gilden DM; Soumerai SB
    JAMA Psychiatry; 2015 Feb; 72(2):179-88. PubMed ID: 25588123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Part D prescription drug benefits and administrative burden in the care of dually eligible psychiatric patients.
    Wilk JE; West JC; Rae DS; Rubio-Stipec M; Chen JJ; Regier DA
    Psychiatr Serv; 2008 Jan; 59(1):34-9. PubMed ID: 18182537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals and medical devices: Medicare Part D.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482890
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicaid eligibility.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-28. PubMed ID: 22416302
    [No Abstract]   [Full Text] [Related]  

  • 12. Coverage and prior authorization of psychotropic drugs under Medicare Part D.
    Huskamp HA; Stevenson DG; Donohue JM; Newhouse JP; Keating NL
    Psychiatr Serv; 2007 Mar; 58(3):308-10. PubMed ID: 17325102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed regulations could limit access to affordable health coverage for workers' children and family members.
    Jacobs K; Graham-Squire D; Roby DH; Kominski GF; Kinane CM; Needleman J; Watson G; Gans D
    Policy Brief UCLA Cent Health Policy Res; 2011 Dec; ():1-11. PubMed ID: 23599987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.
    Hall JP; Kurth NK; Moore JM
    Am J Manag Care; 2007 Jan; 13(1):14-8. PubMed ID: 17227199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy implications of Medicare Part D for adults with mental illness: a qualitative exploration.
    Hensley MA
    Soc Work Public Health; 2012; 27(3):238-49. PubMed ID: 22486429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidality is associated with medication access problems in publicly insured psychiatric patients.
    MoĊ›cicki EK; West JC; Rae DS; Rubio-Stipec M; Wilk JE; Regier DA
    J Clin Psychiatry; 2010 Dec; 71(12):1657-63. PubMed ID: 21190639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual eligibles with mental disorders and Medicare part D: how are they faring?
    Donohue JM; Huskamp HA; Zuvekas SH
    Health Aff (Millwood); 2009; 28(3):746-59. PubMed ID: 19414883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitigating the effects of churning under the Affordable Care Act: lessons from Medicaid.
    Rosenbaum S; Lopez N; Dorley M; Teitelbaum J; Burke T; Miller J
    Issue Brief (Commonw Fund); 2014 Jun; 12():1-8. PubMed ID: 24988615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.